Treatment With Combination of Lenalidomide and Rituximab Achieves Durable Responses in a Long Term Follow up of Patients With Indolent Non‐hodgkin's Lymphoma
Year: 2017
Type: article
Abstract: toxicity assessment of chronically administered therapy for indolent lymphomas.
Source: Hematological Oncology
DOI: 10.1002/hon.2438_79
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2622857175
